Cargando…

Treatment of Chronic Delta Hepatitis

Detalles Bibliográficos
Autor principal:	Rizzetto, Mario
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kowsar 2011
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3234538/ https://www.ncbi.nlm.nih.gov/pubmed/22235212 http://dx.doi.org/10.5812/kowsar.1735143X.759

Ejemplares similares

Treatment of Hepatitis B Virus Cirrhosis
por: Rizzetto, Mario
Publicado: (2012)

Prevalence of Hepatitis Delta Virus (HDV) Infection in Chronic Hepatitis B Patients with Unusual Clinical Pictures
por: Ghamari, Shiva, et al.
Publicado: (2013)

Forty-Five Years after the Discovery of the Hepatitis D Virus: Where Do We Stand?
por: Rizzetto, Mario, et al.
Publicado: (2021)

Endpoints and New Options for Treatment of Chronic Hepatitis D
por: Lok, Anna S., et al.
Publicado: (2021)

Developing New Therapies for Delta Hepatitis: The Race Is On
por: Gençdal, Genco, et al.
Publicado: (2021)

Therapy of Chronic Viral Hepatitis: The Light at the End of the Tunnel?
por: Saracco, Giorgio Maria, et al.
Publicado: (2022)

Clinical Application of Droplet Digital PCR for Hepatitis Delta Virus Quantification
por: Olivero, Antonella, et al.
Publicado: (2022)

A case of autoimmune hepatitis following pegylated interferon treatment of chronic hepatitis delta
por: Enc, Feruze, et al.
Publicado: (2020)

Treatment of Chronic Delta Hepatitis: A Nine-Year Retrospective Analysis
por: Gulsun, Serda, et al.
Publicado: (2011)

Hepatitis delta /
por: García Martín, Monserrat de los Angeles
Publicado: (1988)

How to compare antivirals in the treatment of chronic hepatitis B?
por: Ozaras, Resat, et al.
Publicado: (2009)

Treatment of people diagnosed with chronic hepatitis C virus infection
por: Bulterys, Marc, et al.
Publicado: (2018)

Interferon Alpha-2b Therapy in Chronic Hepatitis Delta
por: Keshvari, Maryam, et al.
Publicado: (2014)

Gamma Delta T-lymphocytes in Hepatitis C and Chronic Liver Disease
por: Rajoriya, Neil, et al.
Publicado: (2014)

A New Treatment for Chronic Hepatitis B and D Offers Novel Insights Into Obesity and Hepatic Steatosis
por: Schierwagen, Robert, et al.
Publicado: (2020)

How to deal with the Delta variant this fall
por: Lee, Jong-Koo
Publicado: (2021)

Chronic hepatitis delta: A state-of-the-art review and new therapies
por: Gilman, Christy, et al.
Publicado: (2019)

The course of COVID-19 infection in patients with chronic hepatitis B and Delta
por: Parlar, Yavuz Emre, et al.
Publicado: (2022)

Is tenofovir disoproxil fumarate an all-powerful weapon in the treatment of chronic hepatitis B?
por: Kim, Ji Hoon, et al.
Publicado: (2015)

Is the tenofovir based therapy almighty for previous treatment failure in chronic hepatitis B?
por: Yim, Hyung Joon
Publicado: (2016)

Treatment of Adolescents With Chronic Hepatitis C Virus Infection: New Regimen on the Block
por: Indolfi, Giuseppe, et al.
Publicado: (2018)

Infection by Hepatitis Delta Virus
por: Taylor, John M.
Publicado: (2020)

Phosphoinositide 3′-kinase delta: turning off BCR signaling in Chronic Lymphocytic Leukemia
por: Hoellenriegel, Julia, et al.
Publicado: (2011)

Persistent Control of Hepatitis B Virus and Hepatitis Delta Virus Infection Following REP 2139‐Ca and Pegylated Interferon Therapy in Chronic Hepatitis B Virus/Hepatitis Delta Virus Coinfection
por: Bazinet, Michel, et al.
Publicado: (2020)

Occult Hepatitis B Virus Infection in Patients With Chronic Hepatitis C Treated With Antiviral Therapy
por: Caviglia, Gian Paolo, et al.
Publicado: (2012)

What Are the Main Differences in the Treatment of Chronic Hepatitis B between Korean Children and Adults?
por: Choe, Byung-Ho
Publicado: (2018)

Hepatitis Delta Virus (HDV) and Delta-Like Agents: Insights Into Their Origin
por: Netter, Hans J., et al.
Publicado: (2021)

Therapeutic Strategies and New Intervention Points in Chronic Hepatitis Delta Virus Infection
por: Guo, Zhimin, et al.
Publicado: (2015)

Pharmacokinetics and pharmacodynamics modeling of lonafarnib in patients with chronic hepatitis delta virus infection
por: Canini, Laetitia, et al.
Publicado: (2017)

Will the COVID-19 pandemic end with the Delta and Omicron variants?
por: Wang, Chaoqi, et al.
Publicado: (2022)

Prevalence and genotype distribution of hepatitis delta virus among chronic hepatitis B carriers in Central Vietnam
por: Nguyen, Hung Minh, et al.
Publicado: (2017)

Prevalence and genotypes distribution of virus hepatitis B and hepatitis delta virus in chronic liver diseases in Kazakhstan
por: Ilyassova, Bibigul S., et al.
Publicado: (2023)

How does hepatic steatosis affect the outcome of patients with chronic hepatitis B?
por: Yu, Jung Hwan, et al.
Publicado: (2019)

Impact of ribavirin dose reduction during treatment in chronic hepatitis C genotype 1 patients
por: Chung, Woo Jin
Publicado: (2012)

Chronic hepatitis C, atherosclerosis and cardiovascular disease: What impact of direct-acting antiviral treatments?
por: Adinolfi, Luigi Elio, et al.
Publicado: (2018)

The truth of the matter: will immune-tolerant chronic hepatitis B patients benefit from antiviral treatment?
por: Jeng, Wen-Juei, et al.
Publicado: (2023)

On the future of therapeutic vaccination in chronic hepatitis B
por: Aguilar Rubido, Julio Cesar
Publicado: (2019)

Chronic Hepatitis C: Pathophysiology and Clinical Issues
por: Abate, Maria Lorena, et al.
Publicado: (2022)

Hepatitis Delta Virus RNA Replication
por: Tseng, Chung-Hsin, et al.
Publicado: (2009)

Is Hepatitis Delta infections important in Brazil?
por: Cicero, Maira Ferreira, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_8aj1jt7an06tl2eqgkm1q8o0nt